Common Contracts

6 similar Securities Purchase Agreement contracts by Novavax Inc, Cleveland Biolabs Inc, Genta Inc De/, Synergy Pharmaceuticals, Inc.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 20th, 2014 • Cleveland Biolabs Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of June 17, 2014, between Cleveland BioLabs, Inc., a Delaware corporation (the “Company”), Mikhail Mogutov, an individual (“Mogutov”) and each purchaser identified on Exhibit A hereto (each, including its successors and assigns, an “Additional Purchaser,” and collectively, the “Additional Purchasers,” and together with Mogutov, each a “Purchaser”, and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 15th, 2011 • Synergy Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November , 2011, between Synergy Pharmaceuticals, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 21st, 2006 • Novavax Inc • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 20, 2006, among Novavax, Inc. a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 1st, 2006 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware

This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2006, among Novavax, Inc. a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 2nd, 2005 • Novavax Inc • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 1, 2005, among Novavax, Inc. a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 16th, 2004 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 14, 2004, among Genta Incorporated, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and